Evidence map›Paper›PMID 25920625›Full record

ArticleTrends in cardiovascular medicine2015

The many facets of RNA-binding protein HuR.

Johnson Rajasingh

Abstract readEditorialComment
In one paragraph

Article in Trends in cardiovascular medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Low Molecular Weight Inhibitors Targeting the RNA-Binding Protein HuR.International journal of molecular sciences · 2023
    Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Johnson RajasinghDivision of Cardiovascular Diseases, Cardiovascular Research Institute and Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS; Department of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, KS. Electronic address: rjohnson9@kumc.edu.

Funding

Epigenetic modification of endothelial progenitor cells into multipotent cellsR21HL097349 · NHLBI · UNIVERSITY OF KANSAS MEDICAL CENTER · PI JOHNSON, RAJASINGH · 2009 to 2010
$432k
NHLBI NIH HHS R21 HL097349NHLBI NIH HHS R21HL97349
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Gene Expression RegulationCardiovascular DiseasesELAV-Like Protein 1HumansRNA StabilityELAV-Like Protein 1

Identifiers

PMID25920625
PMCPMC4747040

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.